Chemistry
Showing 281-300 of 314 Results
-
Paul Wender
Francis W. Bergstrom Professor and Professor, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsMolecular imaging, therapeutics, drug delivery, drug mode of action, synthesis
-
Yilei Wu
Laboratory Services Manager 2, Chemistry
BioAs a research scientist at Stanford University, I am passionate about advancing the field of organic electronics and solar energy conversion. I have over 15 years of experience in designing, synthesizing, and applying novel organic materials for various applications, such as thin-film transistors, solar cells, spintronics, fluorescence imaging, and molecular machines. I work to develop high-performance organic materials for solution printable solar cells and wearable electronics. I leverage my expertise in supramolecular chemistry, thin-film deposition, and device characterization to optimize the donor-acceptor interfaces and bulk morphology of organic photovoltaic materials. My work contributes to the development of flexible and lightweight solar cells that can provide a sustainable and versatile solution for the modern military and civilian needs.
I oversee the operation and management of Chemistry department laboratory teaching facilities. I also oversee and administer health and safety programs and ensure safety compliance.
As instructor, I teach CHEM 100: Chemical Laboratory and Safety Skills. This is a short in-lab course that is only held in the second week of the Autumn quarter. It provides training in basic chemical laboratory procedures and chemical safety to fulfill the safety training requirement for CHEM 121 and more advanced laboratory courses. The following topics are covered: Reading and Understanding Safety Data Sheets (SDS), Exploring Hazards and Risks, Waste Management, Basic Purification (TLC, Extraction, Filtration, etc.) and Analysis Techniques. In spring 2026 I will teach CHEM 121: Understanding the Natural and Unnatural World through Chemistry. -
Yan Xia
Associate Professor of Chemistry
Current Research and Scholarly InterestsPolymer Chemistry, Microporous Polymer Membranes, Responsive Polymers, Degradable Polymers, Polymers with Unique Mechanical Behaviors, Polymer Networks, Organic Electronic Materials
-
Pavan Yadav
Postdoctoral Scholar, Chemistry
BioI am a Postdoctoral Researcher at Stanford University in the laboratory of Professor Paul A. Wender, where I work on the development of delivery technologies for RNA therapeutics, including mRNA, circular RNA (circRNA), and oligonucleotide-based medicines. My current research focuses on lipid nanoparticles (LNPs) and transporter-based systems for targeted nucleic acid delivery, with the goal of advancing the translation of genetic medicines.
I received my Ph.D. in Pharmaceutical Sciences from CSIR–Central Drug Research Institute (CSIR-CDRI), India. During my doctoral training, I specialized in nanomedicine, drug delivery, pharmacokinetics, and bioanalytical method development, with a particular focus on developing nanocarrier-based therapeutic strategies for cancer treatment. Prior to my Ph.D., I earned both my Bachelor of Pharmacy and Master of Pharmacy degrees from Mahatma Jyotiba Phule Rohilkhand University, India.
My research interests span RNA therapeutics, drug delivery, nanomedicine, lipid nanoparticle engineering, pharmacokinetics, and translational pharmaceutical sciences. I have experience in the design, formulation, and biological evaluation of diverse delivery systems, including lipid nanoparticles, liposomes, nanoemulsions, polymeric carriers, and other nanomaterial-based therapeutic platforms. My work integrates formulation science, biological evaluation, and preclinical studies to improve the delivery and performance of therapeutic agents.
I have authored more than 35 peer-reviewed publications in journals such as Nature Communications, ACS Applied Materials & Interfaces, International Journal of Pharmaceutics, Nanomedicine, and Bioanalysis. I am particularly interested in developing innovative delivery approaches that bridge fundamental research and clinical translation, with the ultimate goal of improving treatment options for patients.
